These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 6471663

  • 1. [Malignant pheochromocytoma: blood pressure controlled by labetalol].
    Sugano O, Hirano J, Hirano K, Kubota Y, Numasawa K, Kawamura S.
    Nihon Hinyokika Gakkai Zasshi; 1984 Mar; 75(3):523-7. PubMed ID: 6471663
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Labetalol in the intraoperative control of pheochromocytoma].
    Janjić I, Luetić V.
    Lijec Vjesn; 1983 Mar; 105(7-8):304-6. PubMed ID: 6633151
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical effects of labetalol in 21 patients with phaeochromocytoma (author's transl)].
    Yoshinaga K, Arakawa K, Ikeda M, Ebihara T, Oe N.
    Horumon To Rinsho; 1981 Apr; 29(4):515-22. PubMed ID: 7296922
    [No Abstract] [Full Text] [Related]

  • 8. Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol.
    Rosei EA, Brown JJ, Lever AF, Robertson AS, Robertson JI, Trust PM.
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):809-15. PubMed ID: 990158
    [Abstract] [Full Text] [Related]

  • 9. Effect of labetalol on blood pressure and plasma catecholamine concentrations in patients with phaeochromocytoma.
    Reach G, Thibonnier M, Chevillard C, Corvol P, Milliez P.
    Br Med J; 1980 May 31; 280(6227):1300-1. PubMed ID: 7388518
    [No Abstract] [Full Text] [Related]

  • 10. Labetalol: the nineteen-eighties.
    Robertson JI.
    Br J Clin Pharmacol; 1982 Jun 31; 13(1 Suppl):137S-141S. PubMed ID: 7093098
    [No Abstract] [Full Text] [Related]

  • 11. Labetalol and the management of hypertension.
    Reid JL, Meredith PA, Elliott HL.
    J Cardiovasc Pharmacol; 1981 Jun 31; 3 Suppl 1():S60-8. PubMed ID: 6169961
    [No Abstract] [Full Text] [Related]

  • 12. Hypertensive response to labetalol in phaeochromocytoma.
    Briggs RS, Birtwell AJ, Pohl JE.
    Lancet; 1978 May 13; 1(8072):1045-6. PubMed ID: 76965
    [No Abstract] [Full Text] [Related]

  • 13. [Recurrent hypertensive crises and dyspnea following unilateral adrenalectomy in pheochromocytoma in a 44-year-old patient. Successful combination chemotherapy of malignant pheochromocytoma].
    Saller B, Jacob K, Markl A, Zwiebel FM, Engelhardt D, Mann K.
    Internist (Berl); 1990 Jan 13; 31(1):78-81. PubMed ID: 2307558
    [No Abstract] [Full Text] [Related]

  • 14. An unusual presentation of a pheochromocytoma.
    Lewis S, Dirnhuber M, Soar J.
    J Cardiothorac Vasc Anesth; 2006 Jun 13; 20(3):390-3. PubMed ID: 16750743
    [No Abstract] [Full Text] [Related]

  • 15. Labetalol and phaeochromocytoma.
    Navaratnarajah M, White DC.
    Br J Anaesth; 1984 Oct 13; 56(10):1179. PubMed ID: 6477797
    [No Abstract] [Full Text] [Related]

  • 16. [Absence of labetalol interference on urine metanephrine determination in hypertensive patients].
    Girerd X, Billaud EM, Sorrel-Dejerine A, Ropers J, Safavian A, Safar M, Laurent S.
    Arch Mal Coeur Vaiss; 1992 Aug 13; 85(8):1231-4. PubMed ID: 1482264
    [Abstract] [Full Text] [Related]

  • 17. [Metastatic malignant pheochromocytoma: treatment with alpha-methyl-para-tyrosine].
    Tcherdakoff P, Ménard J, Bedrossian J, Vaysse J, Alexandre JM, Milliez P.
    Sem Hop; 1972 May 26; 48(25):1779-87. PubMed ID: 4405188
    [No Abstract] [Full Text] [Related]

  • 18. Adrenal phaeochromocytoma in familial neurofibromatosis with initial control of hypertension by labetalol.
    Stewart PA.
    J R Soc Med; 1982 Apr 26; 75(4):276-8. PubMed ID: 6802972
    [No Abstract] [Full Text] [Related]

  • 19. Labetalol, an alpha- and beta-adrenergic blocking drug in the treatment of hypertension.
    Rosei EA, Fraser R, Morton JJ, Brown JJ, Lever AF, Robertson JI, Trust PM.
    Am Heart J; 1977 Jan 26; 93(1):124-5. PubMed ID: 12654
    [No Abstract] [Full Text] [Related]

  • 20. Labetalol: a review of its pharmacology and therapeutic use in hypertension.
    Brogden RN, Heel RC, Speight TM, Avery GS.
    Drugs; 1978 Apr 26; 15(4):251-70. PubMed ID: 25757
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.